Translational Science & Applied Innovation

Innovation Built on
Deep Scientific Capability.

HH Global Holdings' innovation programme is the output of deep translational science, evidence generation and regulatory understanding. Where the science demands a new platform, methodology or framework, we build it: rapid diagnostics that translate laboratory rigour into point-of-care use, assay platforms that accelerate biomarker discovery, and bioinformatics architectures that turn complex data into regulatory-grade evidence. Each programme below is grounded in a specific scientific problem and a defined evidentiary requirement.

Diagnostics & Therapeutics

Rapid diagnostic and therapeutic technologies enabling point-of-care detection and intervention across human, animal, and environmental health applications.

Biotechnology Platforms

Assay and translational platforms enabling high-throughput biomarker identification, drug discovery, and translational development.

Data & Health Intelligence

Data-driven systems and analytical approaches converting complex datasets into defensible insights across human, animal, and environmental health domains.

Examples below are illustrative — not the sole focus areas within each category.

Diagnostics & Therapeutics

  • Multiplex Lateral Flow Test (UK Patent-Pending), True multiplexing on a single strip using microarray spotted technology. Can spot 20–60 individual proteins or antibodies onto a single flow cell, detect both proteins AND antibodies in a single test. One of the first platforms to enable dual detection. Optimised for different porosities and incubation times per target.

Biotechnology Platforms

  • Extended Patent Library, Active pipeline of patent applications spanning animal health diagnostics, agricultural testing platforms, and agri-environmental monitoring systems. Sector-specific applications of core technologies.

Data & Health Intelligence

  • One Health Data Integration, Integrated analytical framework bridging human, animal, and environmental health data. Epidemiological modelling, One Health pathway analysis, integrated risk assessment.
  • Evidence Generation Workflows, Systematic approaches to evidence generation, validation, and regulatory documentation. Designed to support rapid translation from bench to bedside to regulation.